BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stratedigm Announces the Launch of the A600 High Throughput Auto Sampler With Flat-6 Technology TM


3/7/2012 9:11:22 AM

San Jose, CA., March 3, 2012- Stratedigm announces the commercial launch of its A600 High Throughput Auto Sampler (HTAS). The A600 HTAS compliments the company’s existing line of analyzers which range from the entry level two laser, eight parameter SE520 model to Stratedigm’s flagship, the S1000Ex which comes equipped with up to four laser and eighteen parameters.

The A600 HTAS shares the same platform-based design philosophy utilized in Stratedigm’s existing flow cytometers. It can be configured as an entry-level model to fit within budgetary constraints while allowing future upgrades with options such as: barcode reader, digital temperature control, and interface to Stratedigm’s A700 Hotel, scheduled for launch in 2012.

“The A600 HTAS is Stratedigm’s building block in the arena of automation and high-content data acquisition and analysis. It has been rapidly adopted by core labs across the nation such as Yale Medical School, Harvard Medical School, and the University of Oklahoma along with private BioTech and Pharma companies during its early access stage, which created significant commercial demand. Stratedigm will continue to expand its presence in the field of automation throughout 2012 with the launch of additional products and software in preparation for completing their suite of flow cytometry instrumentation in upcoming years,” noted Shervin Javadi, Stratedigm’s CEO.

Contact Info:

Iryna Balakshyna

408.884.4029 (Voice)

408.351.7700 (fax)



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES